(A): Biochemical, recurrence-free survival in all patients. The 5-year biochemical recurrence-free survival rates in the radical prostatectomy (RP) and external beam radiation therapy (EBRT) groups were 62.3% and 76.2%, respectively. (B)–(D): Biochemical, recurrence-free survival in low, intermediate and high-risk patients, repectively.